SEO Title: 3 December IPO All Details 2025: Meesho, Aequs, Vidya Wires Analysis, GMP & Review
1. Meesho Limited IPO (Mainboard)
Status: OPENS TODAY (Dec 3 - Dec 5, 2025)[1][2][3][4][5][6]
![Image: Meesho Company Logo and App Interface]
Price Band: ₹105 – ₹111 per share[1][3][7][8][9][10]
Lot Size: 135 Shares
Total Issue Size: ₹5,421 Cr[1][8][9][10]
Grey Market Premium (GMP): ~₹46 - ₹49 (42-44% Premium) indicating a strong potential listing.[1]
📊 Company Analysis:
Business Model: Meesho is India's leading "social commerce" and value e-commerce platform, focusing on Tier 2+ cities.[1][2] It operates on a low-commission model, making it attractive for small sellers.[1][2]
Financial Health:
Revenue (FY25): ₹9,389 Cr (Significant growth from ₹7,615 Cr in FY24).[1][8]
Profit/Loss (FY25): Loss of ₹3,941 Cr (Widened from ₹327 Cr in FY24 largely due to one-time exceptional items like ESOPs and restructuring costs).[1][8][11]
Strengths:
Massive Reach: Dominates the budget-friendly segment with over 150 million annual transacting users.[1]
Softbank Backing: Strong institutional support.[1]
Asset-Light: Does not hold inventory, reducing operational risks.[1][2]
Risks:
Widening Losses: The sharp increase in losses in FY25 is a concern for conservative investors.[1]
Competition: Fierce competition from Amazon Bazaar and Flipkart Shopsy.[1]
✅ Verdict: Apply for Listing Gains. The high GMP and brand recall suggest a strong debut, though long-term holding requires monitoring their path to profitability.[1]
2. Aequs Limited IPO (Mainboard)
Status: OPENS TODAY (Dec 3 - Dec 5, 2025)[1][2][3][4][5][6][12][13]
![Image: Aequs Manufacturing Plant and Aerospace Components]
Price Band: ₹118 – ₹124 per share[1][4][7][8][13][14][15][16]
Lot Size: 120 Shares
Total Issue Size: ₹921.81 Cr[1][4][6][7][8][13][15]
Grey Market Premium (GMP): ~₹44 - ₹46 (35-37% Premium).[1]
📊 Company Analysis:
Business Model: Aequs is a vertically integrated precision manufacturing company.[1][4][15][17] It primarily serves the Aerospace sector (supplying to giants like Airbus/Boeing supply chains) and has diversified into consumer goods (toys, appliances).[1][2][8][18]
Financial Health:
Revenue: ~₹959 Cr (FY25).[1][8][17][19]
Profitability: Currently loss-making (~₹102 Cr Loss in FY25).[1][17]
Strengths:
Niche Moat: One of the few Indian companies with a fully integrated aerospace ecosystem (SEZ in Belagavi).
Global Clients: Strong export order book.[1]
Risks:
Sector Concentration: Heavily dependent on the cyclical aerospace industry.[1]
Financials: Consistent losses in recent years make it a risky bet for pure fundamental investors.[1]
✅ Verdict: Apply for Listing Gains. The unique "Make in India" defense/aerospace theme is attracting strong market interest despite the financial losses.[1]
3. Vidya Wires Limited IPO (Mainboard)
Status: OPENS TODAY (Dec 3 - Dec 5, 2025)[1][2][3][5][12][20][21]
![Image: Vidya Wires Copper Winding Products]
Price Band: ₹48 – ₹52 per share[1][7][8][12][16][22]
Lot Size: 288 Shares
Total Issue Size: ₹300 Cr[1][8]
Grey Market Premium (GMP): ~₹6 (11-12% Premium).[1][2]
📊 Company Analysis:
Business Model: Manufacturers of winding wires (copper/aluminium) used in transformers, automobiles, and power transmission.[1][2][8]
Financial Health:
Revenue (FY25): ₹1,486 Cr (Up 25% YoY).[1][8]
Profit (FY25): ₹40.87 Cr (Up 59% YoY).[1][8]
Strengths:
Profitable: Unlike Meesho and Aequs, Vidya Wires is profitable and growing.[1][2][8]
Valuation: Reasonably valued compared to industry peers.
Risks:
Low Margins: The wire business is a volume game with thin profit margins (PAT Margin ~2.7%).[1][23]
Commodity Risk: Highly sensitive to copper price fluctuations.[1]
✅ Verdict: Good for Long Term. While listing gains might be modest compared to Meesho, the fundamentals are stable for long-term wealth creation.[1]
4. Suraksha Diagnostic IPO (Mainboard)
Status: CLOSING TODAY (Dec 3, 2025)[1][2][4][24]
![Image: Suraksha Diagnostic Lab Interior]
Price Band: ₹420 – ₹441 per share[1][8]
Subscription Status (Day 3): Subscribed 1.27x (Barely crossed 100%).
GMP: Flat / ₹2 Premium.[1][8]
📊 Analysis:
The IPO has received a tepid response. High valuation and competitive pressure in the diagnostics sector (vs Dr. Lal PathLabs, Metropolis) have kept investor enthusiasm low.
Recommendation: Avoid / High Risk. Listing is likely to be flat or at a discount.[1]
Summary Table: Which One to Choose?
| Meesho | High (Loss Making) | ⭐⭐⭐⭐ (42%) | Apply for high listing gains.[1] |
| Aequs | High (Loss Making) | ⭐⭐⭐ (37%) | Apply for "Defense/Aerospace" theme hype.[1][2] |
| Vidya Wires | Low (Profitable) | ⭐⭐ (12%) | Apply for steady long-term returns.[1][2] |
| Suraksha Diag. | Medium | ⭐ (0%) | Avoid (Weak demand).[1][2] |
(Disclaimer: This analysis is for educational purposes. Please consult your financial advisor before investing.)
No comments:
Post a Comment